{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T02:42:18Z","timestamp":1709174538564},"reference-count":72,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T00:00:00Z","timestamp":1218153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"DOI":"10.1007\/s00393-008-0341-2","type":"journal-article","created":{"date-parts":[[2008,8,6]],"date-time":"2008-08-06T12:50:31Z","timestamp":1218027031000},"source":"Crossref","is-referenced-by-count":0,"title":["Dermatologische Krankheitsbilder in der Rheumatologie","Dermatological symptoms in rheumatology"],"prefix":"10.1007","author":[{"given":"E.","family":"Aberer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,8]]},"reference":[{"key":"341_CR1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","volume":"4","author":"Gilliam","year":"1981","unstructured":"Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4: 471\u2013475","journal-title":"J Am Acad Dermatol"},{"key":"341_CR2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00105-006-1138-3","volume":"57","author":"Kuhn","year":"2006","unstructured":"Kuhn A, Gensch K, Stander S et al. (2006) Cutaneous lupus erythematosus. Part 2: diagnostics and therapy. Hautarzt 57: 345\u2013348 quiz 359","journal-title":"Hautarzt"},{"key":"341_CR3","unstructured":"Sticherling M (2005) Lupus erythematosus: Chronic cutaneous lupus erythematosus In: Hertl M (ed) Autoimmune diseases of the skin, 2nd. Springer, Wien NewYork pp 183\u2013202"},{"key":"341_CR4","first-page":"395","volume":"54","author":"Su","year":"1994","unstructured":"Su WP, Perniciaro C, Rogers RS 3rd et al. (1994) Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis 54: 395\u2013399","journal-title":"Cutis"},{"key":"341_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2007.09.039","volume":"58","author":"Remy-Leroux","year":"2008","unstructured":"Remy-Leroux V, Leonard F, Lambert D et al. (2008) Comparison of histopathologic-clinical characteristics of Jessner\u2019s lymphocytic infiltration of the skin and lupus erythematosus tumidus: Multicenter study of 46 cases. J Am Acad Dermatol 58: 217\u2013223","journal-title":"J Am Acad Dermatol"},{"key":"341_CR6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00000372-199908000-00008","volume":"21","author":"Ruiz","year":"1999","unstructured":"Ruiz H, Sanchez JL (1999) Tumid lupus erythematosus. Am J Dermatopathol 21: 356\u2013360","journal-title":"Am J Dermatopathol"},{"key":"341_CR7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1600-0625.2007.00556.x","volume":"16","author":"Wenzel","year":"2007","unstructured":"Wenzel J, Tuting T (2007) Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. Exp Dermatol 16: 454\u2013463","journal-title":"Exp Dermatol"},{"key":"341_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archderm.144.2.173","volume":"144","author":"Bonilla-Martinez","year":"2008","unstructured":"Bonilla-Martinez ZL, Albrecht J, Troxel AB et al. (2008) The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus. Arch Dermatol 144: 173\u2013180","journal-title":"Arch Dermatol"},{"key":"341_CR9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1191\/0961203306lu2298xx","volume":"15","author":"Aringer","year":"2006","unstructured":"Aringer M, Stamm TA, Pisetsky DS et al. (2006) ICF core sets: how to specify impairment and function in systemic lupus erythematosus. Lupus 15: 248\u2013253","journal-title":"Lupus"},{"key":"341_CR10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","volume":"20","author":"Kalia","year":"2007","unstructured":"Kalia S, Dutz JP (2007) New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther 20: 160\u2013174","journal-title":"Dermatol Ther"},{"key":"341_CR11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D35DS6T179","volume":"7","author":"Werth","year":"2001","unstructured":"Werth V (2001) Current treatment of cutaneous lupus erythematosus. Dermatol Online J 7: 2","journal-title":"Dermatol Online J"},{"key":"341_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-3083.2006.01737.x","volume":"63","author":"Toubi","year":"2006","unstructured":"Toubi E, Kessel A, Rosner I et al. (2006) The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus. Scand J Immunol 63: 299\u2013303","journal-title":"Scand J Immunol"},{"key":"341_CR13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1067\/mjd.2001.114733","volume":"45","author":"Zhu","year":"2001","unstructured":"Zhu YI, Stiller MJ (2001) Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol 45: 420\u2013434","journal-title":"J Am Acad Dermatol"},{"key":"341_CR14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archderm.142.3.399","volume":"142","author":"Ujiie","year":"2006","unstructured":"Ujiie H, Shimizu T, Ito M et al. (2006) Lupus erythematosus profundus successfully treated with dapsone: review of the literature. Arch Dermatol 142: 399\u2013401","journal-title":"Arch Dermatol"},{"key":"341_CR15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D330M4B5KR","volume":"8","author":"Wolf","year":"2002","unstructured":"Wolf R, Matz H, Orion E et al. (2002) Dapsone. Dermatol Online J 8: 2","journal-title":"Dermatol Online J"},{"key":"341_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1440-0960.2008.00437.x","volume":"49","author":"Ludgate","year":"2008","unstructured":"Ludgate MW, Greig DE (2008) Bullous systemic lupus erythematosus responding to dapsone. Australas J Dermatol 49: 91\u201393","journal-title":"Australas J Dermatol"},{"key":"341_CR17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0167-5699(99)01531-5","volume":"20","author":"Marriott","year":"1999","unstructured":"Marriott JB, Muller G, Dalgleish AG (1999) Thalidomide as an emerging immunotherapeutic agent. Immunol Today 20: 538\u2013540","journal-title":"Immunol Today"},{"key":"341_CR18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0190-9622(96)90122-X","volume":"35","author":"Tseng","year":"1996","unstructured":"Tseng S, Pak G, Washenik K et al. (1996) Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol 35: 969\u2013979","journal-title":"J Am Acad Dermatol"},{"key":"341_CR19","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/archderm.1993.04540010026002","volume":"129","author":"Holm","year":"1993","unstructured":"Holm AL, Bowers KE, McMeekin TO et al. (1993) Chronic cutaneous lupus erythematosus treated with thalidomide. Arch Dermatol 129: 1548\u20131550","journal-title":"Arch Dermatol"},{"key":"341_CR20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344\u2013347","journal-title":"N Engl J Med"},{"key":"341_CR21","doi-asserted-by":"crossref","unstructured":"Bohan A, Peter JB, Bowman RL et al. (1977) Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56: 255\u2013286","DOI":"10.1097\/00005792-197707000-00001"},{"key":"341_CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clindermatol.2006.07.001","volume":"24","author":"Callen","year":"2006","unstructured":"Callen JP, Wortmann RL (2006) Dermatomyositis. Clin Dermatol 24: 363\u2013373","journal-title":"Clin Dermatol"},{"key":"341_CR23","first-page":"438","volume":"35","author":"Andras","year":"2008","unstructured":"Andras C, Ponyi A, Constantin T et al. (2008) Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35: 438\u2013444","journal-title":"J Rheumatol"},{"key":"341_CR24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","volume":"12","author":"Targoff","year":"2000","unstructured":"Targoff IN (2000) Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol 12: 475\u2013481","journal-title":"Curr Opin Rheumatol"},{"key":"341_CR25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00393-007-0226-9","volume":"66","author":"Richter","year":"2007","unstructured":"Richter J, Iking-Konert C (2007) Current treatments of dermatomyositis and polymyositis. Z Rheumatol 66: 686\u2013692","journal-title":"Z Rheumatol"},{"key":"341_CR26","doi-asserted-by":"crossref","unstructured":"Hunzelmann N, Krieg T (2005) Progressive systemic scleroderma. In: Hertl M (ed) Autoimmune diseases of the skin 2nd Springer Wien NewYork 165\u2013182","DOI":"10.1007\/3-211-27377-8_8"},{"key":"341_CR27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00393-006-0065-0","volume":"65","author":"Genth","year":"2006","unstructured":"Genth E, Krieg T (2006) Systemic sclerosis - diagnosis and classification. Z Rheumatol 65: 268\u2013274","journal-title":"Z Rheumatol"},{"key":"341_CR28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0190-9622(88)70070-5","volume":"18","author":"Krieg","year":"1988","unstructured":"Krieg T, Meurer M (1988) Systemic scleroderma. Clinical and pathophysiologic aspects. J Am Acad Dermatol 18: 457\u2013481","journal-title":"J Am Acad Dermatol"},{"key":"341_CR29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF02230332","volume":"15","author":"Blockmans","year":"1996","unstructured":"Blockmans D, Beyens G, Verhaeghe R (1996) Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol 15: 148\u2013153","journal-title":"Clin Rheumatol"},{"key":"341_CR30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/art.1780230208","volume":"23","author":"Maricq","year":"1980","unstructured":"Maricq HR, LeRoy EC, D\u2019Angelo WA et al. (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23: 183\u2013189","journal-title":"Arthritis Rheum"},{"key":"341_CR31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.1780330508","volume":"33","author":"Genth","year":"1990","unstructured":"Genth E, Mierau R, Genetzky P et al. (1990) Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum 33: 657\u2013665","journal-title":"Arthritis Rheum"},{"key":"341_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RCT.0b013e31805d08ee","volume":"32","author":"Prasad","year":"2008","unstructured":"Prasad SR, Jagirdar J (2008) Nephrogenic systemic fibrosis\/nephrogenic fibrosing dermopathy: a primer for radiologists. J Comput Assist Tomogr 32: 1\u20133","journal-title":"J Comput Assist Tomogr"},{"key":"341_CR33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2133.1996.tb01166.x","volume":"135","author":"Bottomley","year":"1996","unstructured":"Bottomley WW, Goodfield MJ, Sheehan-Dare RA (1996) Digital calcification in systemic sclerosis: effective treatment with good tissue preservation using the carbon dioxide laser. Br J Dermatol 135: 302\u2013304","journal-title":"Br J Dermatol"},{"key":"341_CR34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.berh.2007.09.001","volume":"21","author":"Tzioufas","year":"2007","unstructured":"Tzioufas AG, Voulgarelis M (2007) Update on Sjogren\u2019s syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 21: 989\u20131010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"341_CR35","doi-asserted-by":"crossref","unstructured":"Ramos-Casals M, Anaya JM, Garcia-Carrasco M et al. (2004) Cutaneous vasculitis in primary Sjogren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 83: 96\u2013106","DOI":"10.1097\/01.md.0000119465.24818.98"},{"key":"341_CR36","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/jnnp.57.8.983","volume":"57","author":"Gemignani","year":"1994","unstructured":"Gemignani F, Marbini A, Pavesi G et al. (1994) Peripheral neuropathy associated with primary Sjogren\u2019s syndrome. J Neurol Neurosurg Psychiatry 57: 983\u2013986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"341_CR37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archderm.1987.01660300123025","volume":"123","author":"Alexander","year":"1987","unstructured":"Alexander E, Provost TT (1987) Sjogren\u2019s syndrome. Association of cutaneous vasculitis with central nervous system disease. Arch Dermatol 123: 801\u2013810","journal-title":"Arch Dermatol"},{"key":"341_CR38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2169\/internalmedicine.36.62","volume":"36","author":"Konishi","year":"1997","unstructured":"Konishi M, Ohosone Y, Matsumura M et al. (1997) Mixed-cryoglobulinemia associated with cutaneous vasculitis and pulmonary symptoms. Intern Med 36: 62\u201367","journal-title":"Intern Med"},{"key":"341_CR39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/art.1780360122","volume":"36","author":"Jubert","year":"1993","unstructured":"Jubert C, Cosnes A, Clerici T et al. (1993) Sjogren\u2019s syndrome and cutaneous B cell lymphoma revealed by anetoderma. Arthritis Rheum 36: 133\u2013134","journal-title":"Arthritis Rheum"},{"key":"341_CR40","unstructured":"Taws Orlick K, Craig SD, Jorizzo JL (1996) Rheumatoid arthritis. In: Sontheimer R, Provost TT (eds) Cutaneous manifestations of rheumatic disease. Williams&Wilkins, Baltimore Philadelphia Hong Kong London Munich Sydney Tokyo 171\u2013175"},{"key":"341_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0560.2003.300101.x","volume":"30","author":"Magro","year":"2003","unstructured":"Magro CM, Crowson AN (2003) The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol 30: 1\u201310","journal-title":"J Cutan Pathol"},{"key":"341_CR42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-2-19","volume":"2","author":"Wollina","year":"2007","unstructured":"Wollina U (2007) Pyoderma gangrenosum-a review. Orphanet J Rare Dis 2: 19","journal-title":"Orphanet J Rare Dis"},{"key":"341_CR43","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","volume":"72","author":"Lindor","year":"1997","unstructured":"Lindor NM, Arsenault TM, Solomon H et al. (1997) A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72: 611\u2013615","journal-title":"Mayo Clin Proc"},{"key":"341_CR44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0560.2003.00024.x","volume":"30","author":"Crowson","year":"2003","unstructured":"Crowson AN, Mihm MC jr, Magro C (2003) Pyoderma gangrenosum: a review. J Cutan Pathol 30: 97\u2013107","journal-title":"J Cutan Pathol"},{"key":"341_CR45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0733-8635(01)00029-8","volume":"20","author":"Powell","year":"2002","unstructured":"Powell FC, O\u2019Kane M (2002) Management of pyoderma gangrenosum. Dermatol Clin 20: 347\u2013355 viii","journal-title":"Dermatol Clin"},{"key":"341_CR46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2004.09.006","volume":"52","author":"Iqbal","year":"2005","unstructured":"Iqbal M, Kolodney MS (2005) Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol 52: 118\u2013120","journal-title":"J Am Acad Dermatol"},{"key":"341_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1610-0387.2006.06172.x","volume":"4","author":"Nast","year":"2006","unstructured":"Nast A, Kopp IB, Augustin M et al. (2006) S3-Guidelines for the therapy of psoriasis vulgaris. J Dtsch Dermatol Ges 4(Suppl 2): 1\u2013126","journal-title":"J Dtsch Dermatol Ges"},{"key":"341_CR48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2249.1997.d01-886.x","volume":"107","author":"Valdimarsson","year":"1997","unstructured":"Valdimarsson H, Sigmundsdottir H, Jonsdottir I (1997) Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin? Clin Exp Immunol 107(Suppl 1): 21\u201324","journal-title":"Clin Exp Immunol"},{"key":"341_CR49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.clindermatol.2007.08.015","volume":"25","author":"Fry","year":"2007","unstructured":"Fry L, Baker BS (2007) Triggering psoriasis: the role of infections and medications. Clin Dermatol 25: 606\u2013615","journal-title":"Clin Dermatol"},{"key":"341_CR50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaad.2005.02.034","volume":"53","author":"Tomi","year":"2005","unstructured":"Tomi NS, Kranke B, Aberer E (2005) Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma and in healthy control subjects. J Am Acad Dermatol 53: 67\u201372","journal-title":"J Am Acad Dermatol"},{"key":"341_CR51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200001030-00003","volume":"1","author":"Tsankov","year":"2000","unstructured":"Tsankov N, Angelova I, Kazandjieva J (2000) Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol 1: 159\u2013165","journal-title":"Am J Clin Dermatol"},{"key":"341_CR52","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2133.2005.06862.x","volume":"153","author":"Grover","year":"2005","unstructured":"Grover C, Reddy BS, Uma Chaturvedi K (2005) Diagnosis of nail psoriasis: importance of biopsy and histopathology. Br J Dermatol 153: 1153\u20131158","journal-title":"Br J Dermatol"},{"key":"341_CR53","unstructured":"Alamanos Y, Voulgari PV, Drosos AA (2008) Incidence and prevalence of psoriatic arthritis: A Systematic Review. J Rheumatol"},{"key":"341_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.2007.080952","volume":"67","author":"McGonagle","year":"2008","unstructured":"McGonagle D, Tan AL, Benjamin M (2008) The biomechanical link between skin and joint disease in psoriasis and psoriatic arthritis: what every dermatologist needs to know. Ann Rheum Dis 67: 1\u20134","journal-title":"Ann Rheum Dis"},{"key":"341_CR55","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00105-005-0995-5","volume":"56","author":"Hofmann","year":"2005","unstructured":"Hofmann H (2005) Lyme borreliosis. Cutaneous manifestation. Hautarzt 56: 783\u2013795 quiz 796","journal-title":"Hautarzt"},{"key":"341_CR56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/rheumatology\/37.3.347","volume":"37","author":"Gerster","year":"1998","unstructured":"Gerster JC, Peter O (1998) Jaccoud\u2019s arthropathy in acrodermatitis chronica atrophicans. Br J Rheumatol 37: 347\u2013348","journal-title":"Br J Rheumatol"},{"key":"341_CR57","first-page":"533","volume":"114","author":"Maraspin","year":"2002","unstructured":"Maraspin V, Ruzic-Sabljic E, Strle F (2002) Isolation of borrelia burgdorferi sensu lato from a fibrous nodule in a patient with acrodermatitis chronica atrophicans. Wien Klin Wochenschr 114: 533\u2013534","journal-title":"Wien Klin Wochenschr"},{"key":"341_CR58","doi-asserted-by":"crossref","unstructured":"Wu IB, Schwartz RA (2008) Reiter\u2019s syndrome: The classic triad and more. J Am Acad Dermatol","DOI":"10.1016\/j.jaad.2008.02.047"},{"key":"341_CR59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2340\/0001555564352354","volume":"64","author":"Benoldi","year":"1984","unstructured":"Benoldi D, Alinovi A, Bianchi G et al. (1984) Reiter\u2019s disease: successful treatment of the skin manifestations with oral etretinate. Acta Derm Venereol 64: 352\u2013354","journal-title":"Acta Derm Venereol"},{"key":"341_CR60","first-page":"105","volume":"17","author":"Blanche","year":"1999","unstructured":"Blanche P (1999) Acitretin and AIDS-related Reiter\u2019s disease. Clin Exp Rheumatol 17: 105\u2013106","journal-title":"Clin Exp Rheumatol"},{"key":"341_CR61","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000107621","volume":"215","author":"Kaya","year":"2007","unstructured":"Kaya G, Saurat JH (2007) Dermatoporosis: a chronic cutaneous insufficiency\/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments. Dermatology 215: 284\u2013294","journal-title":"Dermatology"},{"key":"341_CR62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10067-007-0753-4","volume":"27","author":"Komatsuda","year":"2008","unstructured":"Komatsuda A, Okamoto Y, Hatakeyama T et al. (2008) Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus. Clin Rheumatol 27: 395\u2013397","journal-title":"Clin Rheumatol"},{"key":"341_CR63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jbspin.2004.06.002","volume":"72","author":"Michel","year":"2005","unstructured":"Michel F, Navellou JC, Ferraud D et al. (2005) DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Joint Bone Spine 72: 82\u201385","journal-title":"Joint Bone Spine"},{"key":"341_CR64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02229648","volume":"15","author":"Ince","year":"1996","unstructured":"Ince A, Yazici Y, Hamuryudan V et al. (1996) The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): a masked and controlled study. Clin Rheumatol 15: 491\u2013494","journal-title":"Clin Rheumatol"},{"key":"341_CR65","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1398-9995.2006.01058.x","volume":"61","author":"Pichler","year":"2006","unstructured":"Pichler WJ (2006) Adverse side-effects to biological agents. Allergy 61: 912\u2013920","journal-title":"Allergy"},{"key":"341_CR66","first-page":"198","volume":"142","author":"Deng","year":"2006","unstructured":"Deng A, Harvey V, Sina B et al. (2006) Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol 142: 198\u2013202","journal-title":"Arch Dermatol"},{"key":"341_CR67","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/s10165-007-0615-6","volume":"17","author":"Furukawa","year":"2007","unstructured":"Furukawa K, Ohtani T, Furukawa F et al. (2007) Infectious mononucleosis-like syndrome induced by salazosulfapyridine in a patient with rheumatoid arthritis. Mod Rheumatol 17: 492\u2013495","journal-title":"Mod Rheumatol"},{"key":"341_CR68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","volume":"156","author":"Lee","year":"2007","unstructured":"Lee HH, Song IH, Friedrich M et al. (2007) Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 156: 486\u2013491","journal-title":"Br J Dermatol"},{"key":"341_CR69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00403-008-0831-8","volume":"300","author":"Mossner","year":"2008","unstructured":"Mossner R, Thaci D, Mohr J et al. (2008) Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases. Arch Dermatol Res 300: 101\u2013105","journal-title":"Arch Dermatol Res"},{"key":"341_CR70","doi-asserted-by":"crossref","unstructured":"Ramos-Casals M, Brito-Zeron P, Munoz S et al. (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86: 242\u2013251","DOI":"10.1097\/MD.0b013e3181441a68"},{"key":"341_CR71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/ard.2007.075663","volume":"67","author":"Voulgari","year":"2008","unstructured":"Voulgari PV, Markatseli TE, Exarchou SA et al. (2008) Granuloma annulare induced by anti-tumour necrosis factor therapy. Ann Rheum Dis 67: 567\u2013570","journal-title":"Ann Rheum Dis"},{"key":"341_CR72","first-page":"223","volume":"143","author":"de","year":"2007","unstructured":"de Gannes GC, Ghoreishi M, Pope J et al. (2007) Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol 143: 223\u2013231","journal-title":"Arch Dermatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0341-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-008-0341-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0341-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T01:58:00Z","timestamp":1709171880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-008-0341-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,8]]},"references-count":72,"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1007\/s00393-008-0341-2","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,8]]}}}